about
Autologous umbilical cord blood infusion for type 1 diabetesAdult stem or progenitor cells in treatment for type 1 diabetes: current progressTowards a global human embryonic stem cell bank.Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.Stem cells as a therapeutic target for diabetes.Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetesIn vitro pancreas duodenal homeobox-1 enhances the differentiation of pancreatic ductal epithelial cells into insulin-producing cells.Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cellsHUCBCs increase angiopoietin 1 and induce neurorestorative effects after stroke in T1DM ratsEfficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up studyStem cell treatment for type 1 diabetes.Intravenous transplantation of very small embryonic like stem cells in treatment of diabetes mellitus.Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation.Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic ratsIdentity deception: not a crime for a stem cell.Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases.Cell replacement in type 1 diabetes mellitus.Allogeneic islet transplantation.Autologous umbilical cord blood transfusion in very young children with type 1 diabetes.Generation of pancreatic islet cells from human embryonic stem cells.Gene and cell therapy based treatment strategies for inflammatory bowel diseases.Bone marrow stem cell as a potential treatment for diabetes.Applicability of adipose-derived stem cells in type 1 diabetes mellitus.Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin.Suspension Culture Alters Insulin Secretion in Induced Human Umbilical Cord Matrix-Derived Mesenchymal CellsLong-term in vitro growth of human insulin-secreting insulinoma cells.The current status of islet transplantation and its perspectives.The uptake mechanism and biocompatibility of graphene quantum dots with human neural stem cells.Potential role of culture mediums for successful isolation and neuronal differentiation of amniotic fluid stem cells.Autologous Bone Marrow-Derived Stem Cells for Treating Diabetic Neuropathy in Metabolic Syndrome.Critical role of SDF-1/CXCR4 signaling pathway in stem cell homing in the deafened rat cochlea after acoustic trauma.In vitro evaluation of different protocols for the induction of mesenchymal stem cells to insulin-producing cells.Stem Cell Labeling and Tracking with Nanoparticles
P2860
Q24647362-8424F084-F801-4E10-A6C2-52636EF96BBBQ24655207-C8326853-D179-47AE-B5EE-B9DFCB88A16FQ33450344-75153E53-6E6E-4D3E-BC6F-26F6817F1DBEQ33747741-651512A9-5AC7-4692-A5FE-A08BFE12D0EEQ33982394-05332E91-C8DA-4711-8359-A60B6B531344Q34151731-80C1ADF7-9C14-4254-9E34-DD6694F7EFABQ34225614-1263115F-43CB-4D0E-8B8F-0D5737B44BF3Q34233041-35459C76-DFAB-4668-A580-D3F326CE382FQ34270300-8C5DD313-4ECB-4C76-AE4E-FBF531992005Q34319707-1CF88DF4-06D0-4F2A-A37C-A3FD41677839Q34391021-BC3CDCEE-87A0-48C1-ADF9-8C3A08E77C5CQ35307069-7D46B875-02D6-41B7-8C01-EF9EBDA59208Q35585661-268065D0-6BFE-4766-83C6-947546033B5CQ36116497-AE1BF9F9-033F-4708-901D-57B2B1CF6415Q36124315-BAFC4209-084C-444D-AF77-36A4B9EB7426Q36224100-C46D50D4-B56E-4A7A-A1A6-64C35C4CB743Q36362625-3E509C83-546E-483C-8342-F4B0C778DEB7Q36981652-54249A00-6AAC-4341-A20C-5A3A2FE54CCBQ37400863-A727C7CD-D804-4B19-A049-2FAF547FBCDAQ37566325-B4BEBFED-722C-4D1C-92B3-515035156054Q37969759-41D7B8BD-D0A9-4FAF-9000-395C028BD7D2Q38106720-7F17475F-7667-49E6-BF2F-0674D4B506C1Q38332629-D0F24A5D-8929-4088-BC3E-F2AC04DCCF14Q39798764-A8E66A0D-6331-4A27-BAF3-A3F599EB870FQ39832056-2634C878-C5AF-469D-B73C-60EE0F137D50Q40247639-948DD19C-51C6-43E7-B99F-AA6E630D1281Q42279086-1871D726-43FF-41E8-823A-2032541A5514Q42655174-D3BC8A64-50EC-4801-A7FD-D31DF8AED2D9Q46981766-9A6C91D8-34BD-4C0E-BC33-800366551E17Q47094987-83B930E0-1665-4E34-8752-3871537D6F09Q49939569-571D5E9D-9332-42BB-AAA6-69101CDDEC8DQ53535050-D9A1A637-70B3-4507-9527-EC652ADDA767Q57345350-B7FB9628-A8E3-40F2-8F5C-5AF4A60608A1
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Stem-cell therapy for diabetes mellitus.
@ast
Stem-cell therapy for diabetes mellitus.
@en
type
label
Stem-cell therapy for diabetes mellitus.
@ast
Stem-cell therapy for diabetes mellitus.
@en
prefLabel
Stem-cell therapy for diabetes mellitus.
@ast
Stem-cell therapy for diabetes mellitus.
@en
P1433
P1476
Stem-cell therapy for diabetes mellitus.
@en
P2093
Mehboob A Hussain
Neil D Theise
P304
P356
10.1016/S0140-6736(04)16635-X
P407
P577
2004-07-01T00:00:00Z